ArticleCancer discovery2026

Neoadjuvant BO-112 and Hypofractionated Radiation Therapy with or without Nivolumab in Soft-Tissue Sarcoma: Preclinical and Phase I Results.

Jie Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.